Pancreatic cancer is one of the harshest and most challenging cancers to treat, often labeled
as incurable. Chemotherapy continues to be the most popular treatment yet yields a very …

Pancreatic cancer (PC) is a fatal disease that has a poor 5-year survival rate. The poor
prognosis can be attributed to both troublesome detections at the initial stage, which makes …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers
with a median survival of 6 months after diagnosis. Intrinsic resistance to chemotherapeutics …

Pancreatic cancer (PC) is a fatal disease that has a 5-year survival rate of less than 9%. It is
expected to rank second in cancer-related deaths across the United States by 2030. Out of …

Cancer is one of the most prevalent potentially lethal diseases. With the increase in the
number of investigations into the uses of nanotechnology, many nucleic acid (NA)-based …

Pancreatic cancer remains one of the major causes of cancer-related mortality. The majority
of pancreatic cancer patients are diagnosed at the advanced stage with unresectable and …

Neuroblastoma (NB) is the most common extracranial childhood tumor classified in five
stages (1, 2, 3, 4 and 4S), two of which (3 and 4) identify chemotherapy-resistant, highly …

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide due to
its aggressiveness and the challenge to early diagnosis and treatment. In recent decades …

The delivery of small interfering RNAs (siRNA) is an efficient method for gene silencing
through the induction of RNA interference (RNAi). It critically relies, however, on efficient …

In the last few decades, the field of nanomedicine applied to cancer has revolutionized
cancer treatment: several nanoformulations have already reached the market and are …